PCV5 EPROSARTAN VERSUS OTHERANGIOTENSIN-RECEPTOR BLOCKERS COMMONLY USED IN POLAND (IRBESARTAN, LOSARTAN, TELMISARTAN AND VALSARTAN) IN PATIENTS WITH HYPERTENSION-DIRECT ANALYSIS
Abstract
Authors
R Wojcik M Kaczor J Walczak G Nogas